Fund Holdings — Bain Capital Life Sciences Investors, LLC

Total Portfolio Value:
$1.51B
Total Bought:
$596.44M
Total Sold:
$173.21M
Net Transaction:
+$423.23M
Securities
▲▼
SharesValue
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Heartflow, Inc.(HTFL)012,448,158+12,448,158$0$419.00M27.81%+$419.00M
Newamsterdam Pharma Company
ORDINARY SHARES
10,719,11010,719,1100$194.12M$304.85M20.23%+$110.73M
Cidara Therapeutics Inc2,500,6803,020,990+520,310$121.81M$289.29M19.20%+$167.48M
Pharvaris N V
COM
3,303,3813,181,275-122,106$58.14M$79.37M5.27%+$21.23M
Olema Pharmaceuticals, Inc.(OLMA)6,843,9546,843,9540$29.16M$67.00M4.45%+$37.85M
Savara Inc.(SVRA)17,600,62117,600,6210$40.13M$62.83M4.17%+$22.70M
Dianthus Therapeutics, Inc.(DNTH)2,482,2501,315,892-1,166,358$46.24M$51.78M3.44%+$5.54M
Solid Biosciences Inc7,911,6697,911,6690$38.53M$48.81M3.24%+$10.29M
Upstream Bio, Inc.(UPB)2,439,5382,439,5380$26.79M$45.89M3.05%+$19.10M
Rapid Micro Biosystems, Inc.CL A(RPID)8,434,5608,434,5600$29.10M$28.17M1.87%-$927.8K
Tango Therapeutics, Inc.(TNGX)2,712,0082,712,0080$13.89M$22.78M1.51%+$8.90M
Cabaletta Bio, Inc.(CABA)9,677,1259,677,1250$14.71M$22.64M1.50%+$7.94M
Kyverna Therapeutics, Inc.(KYTX)3,368,3703,368,3700$10.34M$20.21M1.34%+$9.87M
Annexon, Inc.(ANNX)5,249,0695,249,0690$12.60M$16.01M1.06%+$3.41M
X4 Pharmaceuticals, Inc.(XFOR)563,8592,436,588+1,872,729$1.07M$8.33M0.55%+$7.26M
Atea Pharmaceuticals, Inc.(AVIR)2,485,6382,485,6380$8.95M$7.21M0.48%-$1.74M
Xilio Therapeutics, Inc.(XLO)4,566,8174,566,8170$3.10M$3.85M0.26%+$743.5K
Mersana Therapeutics Inc0346,545+346,545$0$2.69M0.18%+$2.69M
C4 Therapeutics, Inc.(CCCC)1,111,9101,111,9100$1.59M$2.47M0.16%+$878.4K
Century Therapeutics, Inc.(IPSC)5,410,3613,538,609-1,871,752$3.02M$1.76M0.12%-$1.26M
Newamsterdam Pharma CompanyW EXP 99 99 999
*W EXP 99/99/999
100,000100,0000$800.0K$1.71M0.11%+$911.0K
Disc Medicine, Inc.(IRON)583,5000-583,500$30.90M$0—-$30.90M
Invivyd, Inc.(IVVD)1,799,5950-1,799,595$1.29M$0—-$1.29M
Mersana Therapeutics Inc8,663,6730-8,663,673$2.56M$0—-$2.56M
Nuvalent Inc1,447,2670-1,447,267$110.43M$0—-$110.43M
Page 1 of 1
Bain Capital Life Sciences Investors, LLC — 13F Holdings — Q3 2025 | TickerTrail